[
    [
        {
            "time": "",
            "original_text": "重慶智飛生物凍干人用狂犬病疫苗進入Ⅲ期臨床 今年股價累計上漲25%",
            "features": {
                "keywords": [
                    "智飛生物",
                    "狂犬病疫苗",
                    "Ⅲ期臨床",
                    "股價上漲"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫療",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "重慶智飛生物凍干人用狂犬病疫苗進入Ⅲ期臨床 今年股價累計上漲25%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]